ALL |
META-ANALYSIS |
CITATIONS |
|
Benefit-Cost Summary Statistics Per Participant | ||||||
---|---|---|---|---|---|---|
Benefits to: | ||||||
Taxpayers | $3,094 | Benefits minus costs | $9,738 | |||
Participants | $5,918 | Benefit to cost ratio | $45.67 | |||
Others | $682 | Chance the program will produce | ||||
Indirect | $263 | benefits greater than the costs | 94% | |||
Total benefits | $9,956 | |||||
Net program cost | ($218) | |||||
Benefits minus cost | $9,738 | |||||
Meta-Analysis of Program Effects | ||||||||||||
Outcomes measured | Treatment age | No. of effect sizes | Treatment N | Effect sizes (ES) and standard errors (SE) used in the benefit-cost analysis | Unadjusted effect size (random effects model) | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
First time ES is estimated | Second time ES is estimated | |||||||||||
ES | SE | Age | ES | SE | Age | ES | p-value | |||||
Crime^ Any criminal conviction according to court records, sometimes measured through charges, arrests, incarceration, or self-report. |
37 | 1 | 19 | -1.038 | 0.481 | 38 | -1.038 | 0.481 | 46 | -1.038 | 0.031 | |
Technical violations^^ Violations of the conditions of an individual’s terms of probation, parole, or supervision. |
37 | 1 | 19 | 0.000 | 0.339 | 38 | 0.000 | 0.339 | 46 | 0.000 | 1.000 | |
Anxiety disorder Clinical diagnosis of an anxiety disorder (e.g., general anxiety, panic, social anxiety, obsessive compulsive disorder) or symptoms measured on a validated scale. |
37 | 2 | 79 | -0.603 | 0.173 | 37 | -0.314 | 0.212 | 39 | -0.603 | 0.001 | |
Major depressive disorder Clinical diagnosis of major depression or symptoms measured on a validated scale. |
37 | 2 | 79 | -0.402 | 0.171 | 37 | -0.209 | 0.209 | 39 | -0.402 | 0.018 | |
Post-traumatic stress Clinical diagnosis of post-traumatic stress disorder (PTSD) or symptoms measured on a validated scale. |
37 | 2 | 79 | -0.361 | 0.170 | 37 | -0.361 | 0.170 | 38 | -0.361 | 0.034 | |
Illicit drug use disorder^^ Clinical diagnosis of illicit drug use disorder or symptoms measured on a validated scale. When possible, we exclude cannabis/marijuana use disorder from this outcome. |
37 | 1 | 19 | -0.662 | 0.464 | 38 | 0.000 | 0.187 | 41 | -0.662 | 0.153 | |
Anger or aggression^ Self-reported anger or aggression measured on a validated scale. |
37 | 2 | 79 | -0.362 | 0.171 | 37 | n/a | n/a | n/a | -0.362 | 0.034 |
Detailed Monetary Benefit Estimates Per Participant | ||||||
Affected outcome: | Resulting benefits:1 | Benefits accrue to: | ||||
---|---|---|---|---|---|---|
Taxpayers | Participants | Others2 | Indirect3 | Total |
||
Major depressive disorder | Mortality associated with depression | $0 | $1 | $0 | $42 | $43 |
Anxiety disorder | Labor market earnings associated with anxiety disorder | $2,432 | $5,730 | $0 | $0 | $8,162 |
Post-traumatic stress | Health care associated with PTSD | $661 | $187 | $682 | $330 | $1,860 |
Program cost | Adjustment for deadweight cost of program | $0 | $0 | $0 | ($109) | ($109) |
Totals | $3,094 | $5,918 | $682 | $263 | $9,956 | |
Detailed Annual Cost Estimates Per Participant | ||||
Annual cost | Year dollars | Summary | ||
---|---|---|---|---|
Program costs | $424 | 2023 | Present value of net program costs (in 2023 dollars) | ($218) |
Comparison costs | $206 | 2023 | Cost range (+ or -) | 20% |
Benefits Minus Costs |
Benefits by Perspective |
Taxpayer Benefits by Source of Value |
Benefits Minus Costs Over Time (Cumulative Discounted Dollars) |
The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment. |
Kubiak, S.P., Kim, W.J., Fedock, G., & Bybee, D. (2015). Testing a violence-prevention intervention for incarcerated women using a randomized control trial. Research on Social Work Practice, 25(3), 334-348.
Kubiak, S., Fedock, G., Kim, W.J., & Bybee, D. (2016) Long-term outcomes of a RCT intervention study for women with violent crimes. Journal of the Society for Social Work and Research, 7(4), 661-679.
Messina, N.P. & Calhoun, S. (2021). An experimental study of a peer-facilitated violence prevention program for women in prison. Journal of Interpersonal Violence, 37(17-18).